Association of MTUS1 with cisplatin response in head and neck squamous cell carcinoma: a retrospective cohort analysis of The Cancer Genome Atlas data
Journal of Yeungnam Medical Science · 20.05.2026 · 43 · 35
DOI: 10.12701/jyms.2026.43.35 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Yeungnam Medical Science, online erschienen am 20.05.2026. Verfasst von Eun-Kyong Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Dentistry, School of Dentistry, Kyungpook National University, Daegu, Korea. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Cisplatin-based chemotherapy is a mainstay treatment for head and neck squamous cell carcinoma (HNSC); however, resistance to cisplatin contributes substantially to poor clinical outcomes. Identifying biomarkers associated with cisplatin response may improve prognostic assessment and treatment selection.
Methods
We retrospectively analyzed The Cancer Genome Atlas (TCGA)-HNSC dataset to evaluate the association between microtubule associated scaffold protein 1 (MTUS1) expression and clinical outcomes, with particular emphasis on patients who were cisplatin-treated. Survival analysis was performed using the Kaplan-Meier curves, and differential expression analysis was conducted separately by comparing patients in disease-specific survival (DSS)-living and DSS-deceased groups. MTUS1 messenger RNA and protein levels were examined in cisplatin-sensitive oral cancer cell lines and their paired cisplatin-resistant counterparts using quantitative reverse transcription polymerase chain reaction and western blotting. Functional relevance was assessed by small interfering RNA-mediated MTUS1 knockdown in primary oral squamous cell carcinoma organoids.
Results
MTUS1 protein expression was significantly lower in HNSC tumors than in non-tumor tissues. In the overall TCGA-HNSC cohort, MTUS1 expression was not significantly associated with survival. However, in patients who were cisplatin-treated, higher MTUS1 expression was significantly associated with more favorable DSS. MTUS1 expression was consistently lower in cisplatin-resistant oral cancer cell lines than in their paired cisplatin-sensitive counterparts. Functional experiments further suggested that reduced MTUS1 expression is associated with decreased cisplatin sensitivity and a resistant phenotype.
Conclusion
MTUS1 expression may be associated with clinical outcomes in patients with cisplatin-treated HNSC and is related to cisplatin responsiveness. These findings suggest a role for MTUS1 as a candidate treatment-relevant biomarker and highlight the value of integrating public omics data with experimental validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Preventive Dentistry, School of Dentistry, Kyungpook National University, Daegu, Korea.
- Department of Microbiology and Immunology, School of Dentistry, Kyungpook National University, Daegu, Korea.
- Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook National University, Daegu, Korea.
- Department of Microbiology and Immunology, School of Dentistry, Kyungpook National University, Daegu, Korea. hongsu@knu.ac.kr.
Zitieren
APA
Kim, E. K., Oh, S. Y., Choi, S. Y., Kim, T. L., Lee, H. J., Kwak, S., & Hong, S. H. (2026). Association of MTUS1 with cisplatin response in head and neck squamous cell carcinoma: a retrospective cohort analysis of The Cancer Genome Atlas data. Journal of Yeungnam Medical Science, 43, 35. https://doi.org/10.12701/jyms.2026.43.35
Vancouver
Kim EK, Oh SY, Choi SY, Kim TL, Lee HJ, Kwak S, et al. Association of MTUS1 with cisplatin response in head and neck squamous cell carcinoma: a retrospective cohort analysis of The Cancer Genome Atlas data. Journal of Yeungnam Medical Science. 2026;43:35. doi:10.12701/jyms.2026.43.35
BibTeX
@article{Kim2026,
author = {Kim, Eun-Kyong and Oh, Su Young and Choi, So-Young and Kim, Tae-Lyn and Lee, Heon-Jin and Kwak, Soyoung and Hong, Su-Hyung},
title = {Association of MTUS1 with cisplatin response in head and neck squamous cell carcinoma: a retrospective cohort analysis of The Cancer Genome Atlas data},
journal = {Journal of Yeungnam Medical Science},
year = {2026},
volume = {43},
pages = {35},
doi = {10.12701/jyms.2026.43.35}
}
EUVIMED